Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity.
Saved in:
| Title: | Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity. |
|---|---|
| Authors: | Yee MEM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Zerra PE; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Francis RO; Department of Pathology and Cell Biology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY., Easley KA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA., Lough CM; LifeSouth Community Blood Centers, Gainesville, FL., McCoy JW; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Naseh Z; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Delvadia BB; Transfusion Services, Northside Hospital, Atlanta, GA., Parikh AK; Department of Radiology, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA., Butler HE; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Stowell SR; Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Joiner CH; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA., Josephson CD; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD., Roback JD; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Fasano RM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA. |
| Source: | Blood advances [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4439-4449. |
| Publication Type: | Journal Article; Clinical Trial |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42018645 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yee+MEM%22">Yee MEM</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Zerra+PE%22">Zerra PE</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Francis+RO%22">Francis RO</searchLink>; Department of Pathology and Cell Biology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY.<br /><searchLink fieldCode="AU" term="%22Easley+KA%22">Easley KA</searchLink>; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Lough+CM%22">Lough CM</searchLink>; LifeSouth Community Blood Centers, Gainesville, FL.<br /><searchLink fieldCode="AU" term="%22McCoy+JW%22">McCoy JW</searchLink>; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Naseh+Z%22">Naseh Z</searchLink>; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Delvadia+BB%22">Delvadia BB</searchLink>; Transfusion Services, Northside Hospital, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Parikh+AK%22">Parikh AK</searchLink>; Department of Radiology, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Butler+HE%22">Butler HE</searchLink>; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Stowell+SR%22">Stowell SR</searchLink>; Joint Program in Transfusion Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Joiner+CH%22">Joiner CH</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Josephson+CD%22">Josephson CD</searchLink>; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Roback+JD%22">Roback JD</searchLink>; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Fasano+RM%22">Fasano RM</searchLink>; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.; Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jul 14; Vol. 10 (13), pp. 4439-4449. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42018645 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025019005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4439 Titles: – TitleFull: Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yee MEM – PersonEntity: Name: NameFull: Zerra PE – PersonEntity: Name: NameFull: Francis RO – PersonEntity: Name: NameFull: Easley KA – PersonEntity: Name: NameFull: Lough CM – PersonEntity: Name: NameFull: McCoy JW – PersonEntity: Name: NameFull: Naseh Z – PersonEntity: Name: NameFull: Delvadia BB – PersonEntity: Name: NameFull: Parikh AK – PersonEntity: Name: NameFull: Butler HE – PersonEntity: Name: NameFull: Stowell SR – PersonEntity: Name: NameFull: Joiner CH – PersonEntity: Name: NameFull: Josephson CD – PersonEntity: Name: NameFull: Roback JD – PersonEntity: Name: NameFull: Fasano RM IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 07 Text: 2026 Jul 14 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 13 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |